↓ Skip to main content

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases

Overview of attention for article published in Frontiers in oncology, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
Published in
Frontiers in oncology, April 2022
DOI 10.3389/fonc.2022.787080
Pubmed ID
Authors

Thomas Pierret, Niccolò Giaj-Levra, Anne-Claire Toffart, Filippo Alongi, Denis Moro-Sibilot, Elisa Gobbini

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 16%
Student > Bachelor 2 11%
Other 2 11%
Student > Doctoral Student 1 5%
Student > Ph. D. Student 1 5%
Other 3 16%
Unknown 7 37%
Readers by discipline Count As %
Medicine and Dentistry 6 32%
Nursing and Health Professions 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Sports and Recreations 1 5%
Engineering 1 5%
Other 0 0%
Unknown 9 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2022.
All research outputs
#8,303,849
of 25,478,886 outputs
Outputs from Frontiers in oncology
#3,098
of 22,568 outputs
Outputs of similar age
#161,624
of 447,937 outputs
Outputs of similar age from Frontiers in oncology
#206
of 1,555 outputs
Altmetric has tracked 25,478,886 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 22,568 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,937 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 1,555 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.